BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23050653)

  • 1. Synthesis and reduction kinetics of sterically shielded pyrrolidine nitroxides.
    Paletta JT; Pink M; Foley B; Rajca S; Rajca A
    Org Lett; 2012 Oct; 14(20):5322-5. PubMed ID: 23050653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of unnatural amino acids functionalized with sterically shielded pyrroline nitroxides.
    Wang Y; Paletta JT; Berg K; Reinhart E; Rajca S; Rajca A
    Org Lett; 2014 Oct; 16(20):5298-300. PubMed ID: 25324010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Reduction Kinetics of Five Ibuprofen-Nitroxides for Ascorbic Acid and Methyl Radicals.
    Sasaki K; Ito T; Fujii HG; Sato S
    Chem Pharm Bull (Tokyo); 2016; 64(10):1509-1513. PubMed ID: 27725505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-phosphorylated nitroxides in the pyrrolidine series: reduction by ascorbate.
    Mathieu C; Mercier A; Witt D; Debmkowski L; Tordo P
    Free Radic Biol Med; 1997; 22(5):803-6. PubMed ID: 9119248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular metabolism of proxyl nitroxides and hydroxylamines.
    Sentjurc M; Pecar S; Chen K; Wu M; Swartz H
    Biochim Biophys Acta; 1991 Mar; 1073(2):329-35. PubMed ID: 1849007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and electrochemical reduction rates of cyclic nitroxides (nitroxyls).
    Morris S; Sosnovsky G; Hui B; Huber CO; Rao NU; Swartz HM
    J Pharm Sci; 1991 Feb; 80(2):149-52. PubMed ID: 2051318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of the tetraethyl substituted pH-sensitive nitroxides of imidazole series with enhanced stability towards reduction.
    Kirilyuk IA; Bobko AA; Grigor'ev IA; Khramtsov VV
    Org Biomol Chem; 2004 Apr; 2(7):1025-30. PubMed ID: 15034626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Sterically Shielded Nitroxides Using the Reaction of Nitrones with Alkynylmagnesium Bromides.
    Dobrynin SA; Gulman MM; Morozov DA; Zhurko IF; Taratayko AI; Sotnikova YS; Glazachev YI; Gatilov YV; Kirilyuk IA
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azethoxyl nitroxide spin labels. ESR studies involving thiourea crystals, model membrane systems and chromatophores, and chemical reduction with ascorbate and dithiothreitol.
    Lee TD; Birrell GB; Bjorkman PJ; Keana JF
    Biochim Biophys Acta; 1979 Feb; 550(3):369-83. PubMed ID: 217428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophilic Reduction-Resistant Spin Labels of Pyrrolidine and Pyrroline Series from 3,4-Bis-hydroxymethyl-2,2,5,5-tetraethylpyrrolidine-1-oxyl.
    Usatov MS; Dobrynin SA; Polienko YF; Morozov DA; Glazachev YI; An'kov SV; Tolstikova TG; Gatilov YV; Bagryanskaya IY; Raizvikh AE; Bagryanskaya EG; Kirilyuk IA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbate- and dehydroascorbic acid-mediated reduction of free radicals in the human erythrocyte.
    Mehlhorn RJ
    J Biol Chem; 1991 Feb; 266(5):2724-31. PubMed ID: 1993652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Simple Method of Synthesis of 3-Carboxy-2,2,5,5-Tetraethylpyrrolidine-1-oxyl and Preparation of Reduction-Resistant Spin Labels and Probes of Pyrrolidine Series.
    Dobrynin SA; Usatov MS; Zhurko IF; Morozov DA; Polienko YF; Glazachev YI; Parkhomenko DA; Tyumentsev MA; Gatilov YV; Chernyak EI; Bagryanskaya EG; Kirilyuk IA
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 1-azaspiro[4.4]nonan-1-oxyls via intramolecular 1,3-dipolar cycloaddition.
    Khoroshunova YV; Morozov DA; Taratayko AI; Gladkikh PD; Glazachev YI; Kirilyuk IA
    Beilstein J Org Chem; 2019; 15():2036-2042. PubMed ID: 31501671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the reduction of nitroxides by flavin mononucleotide.
    Morse PD; Ruuge EK; Petro MJ; Swartz HM
    Biochim Biophys Acta; 1990 Jun; 1034(3):298-302. PubMed ID: 2364087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of structure on the reduction of nitroxide MRI contrast-enhancing agents by ascorbate.
    Keana JF; Van Nice FL
    Physiol Chem Phys Med NMR; 1984; 16(6):477-80. PubMed ID: 6537509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating nitroxides as molecular sensors for imaging of cancer in vivo, based on tissue redox activity.
    Zhelev Z; Gadjeva V; Aoki I; Bakalova R; Saga T
    Mol Biosyst; 2012 Oct; 8(10):2733-40. PubMed ID: 22832934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible reduction of nitroxides to hydroxylamines: roles for ascorbate and glutathione.
    Bobko AA; Kirilyuk IA; Grigor'ev IA; Zweier JL; Khramtsov VV
    Free Radic Biol Med; 2007 Feb; 42(3):404-12. PubMed ID: 17210453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of nitroxides by anthralin and some of its derivatives.
    Pecar S; Schara M; Müller K; Wiegrebe W
    Free Radic Biol Med; 1995 Mar; 18(3):459-65. PubMed ID: 9101236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction kinetics and electrochemistry of tetracarboxylate nitroxides.
    Huang S; Zhang H; Paletta JT; Rajca S; Rajca A
    Free Radic Res; 2018 Mar; 52(3):327-334. PubMed ID: 29402129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxylamines inhibit tyrosine oxidation and nitration: The role of their respective nitroxide radicals.
    Samuni A; Goldstein S
    Free Radic Biol Med; 2020 Nov; 160():837-844. PubMed ID: 32866620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.